Acute cellular rejection after heart transplantation: validation of HEARTBiT, a transcriptomic biomarker
Open Access
- 29 September 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
Abstract
Background and Aims: Acute cellular rejection (ACR) risk is highest within 60 days of heart transplantation (HTx), yet existing minimally invasive surveillance tools lack validation for this high-risk period. This study prospectively validated the diagnostic accuracy of HEARTBiT, a transcriptomic biomarker for detecting moderate-to-severe ACR, including during the early post-operative period. Methods: This prospective diagnostic accuracy study (NCT03575910) enrolled consecutive adult HTx recipients at four tertiary clinical centres. The diagnostic performance of HEARTBiT was evaluated in 336 visits from 117 participants against centralized expert consensus panel endomyocardial biopsy grades. An exploratory analysis of 246 serial visits from 31 participants evaluated the prognostic potential of tracking individual transcriptomic trajectories over time. Results: HEARTBiT accurately detected moderate-to-severe ACR (ISHLT ≥2R) with an overall area under the curve (AUC) of 0.78 [95% confidence interval (CI) 0.70–0.86]. Performance was stable early post-HTx (≤60 days: AUC = 0.78, 95% CI 0.65–0.90) and beyond 60 days (AUC = 0.80, 95% CI 0.72–0.87). Prioritizing high sensitivity (89% early, 100% late; corresponding to ≤1 missed ACR overall) yielded a specificity of 56% in the early period (≤60 days) and 49% beyond 60 days using the pre-specified cutoff (>0.54). Alternatively, adopting an exploratory time-varying threshold (>0.68) beyond 60 days yielded 83% sensitivity and 76% specificity. Importantly, HEARTBiT scores increased weeks before histological detection of ACR by tissue biopsy (slope-based AUC = 0.78, 95% CI 0.60–0.96). Conclusions: HEARTBiT provides a reliable, minimally invasive rule-out signal for moderate-to-severe ACR across the first year post-HTx, particularly during the high-risk early post-operative period. Serial tracking of HEARTBiT score trajectories has potential for prognosis of progression to ACR. These findings support the clinical utility of this biomarker in safely sparing more than 50% of protocol surveillance endomyocardial biopsies.Keywords
Funding Information
- Canadian Institutes of Health Research (PJT-156101)
- Genome British Columbia
This publication has 33 references indexed in Scilit:
- Sex-Specific Considerations in Management and Outcomes of Heart Transplant RecipientsCanadian Journal of Cardiology, 2025
- Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT)The Journal of Heart and Lung Transplantation, 2024
- The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2022
- HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft PatientsCanadian Journal of Cardiology, 2020
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan TransplantationThe Journal of Heart and Lung Transplantation, 2018
- The management of antibodies in heart transplantation: An ISHLT consensus documentThe Journal of Heart and Lung Transplantation, 2018
- The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantationThe Journal of Heart and Lung Transplantation, 2013
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- Whole Blood Genomic Biomarkers of Acute Cardiac Allograft RejectionThe Journal of Heart and Lung Transplantation, 2009
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005